To test the involvement of the reduced PPARγ level in the Aβ25–35-induced cognitive deficits, the rosi treatment was given for consecutive 17 days starting from 2 days before the Aβ25–35 injection (Fig. 2b). The gene discussed is PPARG; the disease is Cognitive impairment.